Literature DB >> 20092995

An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes.

Christian Freise1, Ulrike Erben, Ulf Neuman, Kiyoung Kim, Martin Zeitz, Rajan Somasundaram, Martin Ruehl.   

Abstract

Obesity, the related metabolic syndrome and associated liver diseases represent an epidemic problem and demand for effective therapeutic strategies. In this regard, natural compounds derived from Oriental medicine such as green tea polyphenols influencing adipogenesis attract growing attention. In Korea, an aqueous extract from the Japanese spice bush Lindera obtusiloba is traditionally used for treatment of inflammation and prevention of liver damage. We here investigated effects of the L. obtusiloba extract on cell growth, apoptosis, Wnt signaling and differentiation of (im)mature adipocytes using 3T3-L1, an established cell line for studying adipogenesis. L. obtusiloba extract reduced the de novo DNA synthesis of 3T3-L1 preadipocytes in a concentration dependent manner with an IC(50) of ∼135 μg/ml paralleled by induction of caspase 3/7 mediated apoptosis. Hormone-induced 3T3 L1 differentiation in the presence of L. obtusiloba extract resulted in a reduced accumulation of intracellular lipid droplets by 70%, in down-regulated expression of the adipogenesis-associated proteins glucose transporter-4 and vascular endothelial growth factor, in reduced secretion of the proadipogenic matrix metalloproteinase-2, and in dampened phosphorylation of the Wnt pathway effector protein β-catenin with subsequent diminished expression of the peroxisome proliferator-activated receptor-γ. Treatment of mature adipocytes with L. obtusiloba extract also significantly reduced intracellular lipid droplets. In addition to this strong interference of L. obtusiloba extract with adipogenesis, L. obtusiloba extract exerted anti-inflammatory effects. L. obtusiloba extract significantly attenuated lipopolysaccharide- and tumor necrosis factor α-induced secretion of IL-6 by preadipocytes, thus influencing insulin resistance and inflammatory state characterizing obesity. In conclusion, extracts of L. obtusiloba should be evaluated as a potential complementary treatment option for obesity associated with the metabolic syndrome.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20092995     DOI: 10.1016/j.jnutbio.2009.09.013

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  14 in total

1.  The inhibitor of Ca(2+)-dependent K+ channels TRAM-34 blocks growth of hepatocellular carcinoma cells via downregulation of estrogen receptor alpha mRNA and nuclear factor-kappaB.

Authors:  Christian Freise; Martin Ruehl; Daniel Seehofer; Joachim Hoyer; Rajan Somasundaram
Journal:  Invest New Drugs       Date:  2012-10-02       Impact factor: 3.850

2.  (+)-Episesamin exerts anti-neoplastic effects in human hepatocellular carcinoma cell lines via suppression of nuclear factor-kappa B and inhibition of MMP-9.

Authors:  Christian Freise; Wolfram Trowitzsch-Kienast; Martin Ruehl; Ulrike Erben; Daniel Seehofer; Ki Young Kim; Martin Zeitz; Rajan Somasundaram
Journal:  Invest New Drugs       Date:  2011-11-03       Impact factor: 3.850

3.  An ethanolic extract of Lindera obtusiloba stems causes NO-mediated endothelium-dependent relaxations in rat aortic rings and prevents angiotensin II-induced hypertension and endothelial dysfunction in rats.

Authors:  Jung-Ok Lee; Min-Ho Oak; Sang Hoon Jung; Dong Hyun Park; Cyril Auger; Kyoung Rak Kim; Seung-Woo Lee; Valérie B Schini-Kerth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

4.  The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 promotes enzymatic activity of matrixmetalloproteinase-2 in vitro.

Authors:  C Freise; M Ruehl; U Erben; R W Farndale; R Somasundaram; M M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

5.  Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes.

Authors:  Pratibha V Nerurkar; Yun-Kung Lee; Vivek R Nerurkar
Journal:  BMC Complement Altern Med       Date:  2010-06-29       Impact factor: 3.659

6.  A hepatoprotective Lindera obtusiloba extract suppresses growth and attenuates insulin like growth factor-1 receptor signaling and NF-kappaB activity in human liver cancer cell lines.

Authors:  Christian Freise; Martin Ruehl; Ulrike Erben; Ulf Neumann; Daniel Seehofer; Ki Young Kim; Wolfram Trowitzsch-Kienast; Thorsten Stroh; Martin Zeitz; Rajan Somasundaram
Journal:  BMC Complement Altern Med       Date:  2011-05-12       Impact factor: 3.659

7.  Sida rhomboidea. Roxb leaf extract down-regulates expression of PPARγ2 and leptin genes in high fat diet fed C57BL/6J Mice and retards in vitro 3T3L1 pre-adipocyte differentiation.

Authors:  Menaka C Thounaojam; Ravirajsinh N Jadeja; Umed V Ramani; Ranjitsinh V Devkar; A V Ramachandran
Journal:  Int J Mol Sci       Date:  2011-07-19       Impact factor: 5.923

8.  A Lindera obtusiloba Extract Blocks Calcium-/Phosphate-Induced Transdifferentiation and Calcification of Vascular Smooth Muscle Cells and Interferes with Matrix Metalloproteinase-2 and Metalloproteinase-9 and NF-κB.

Authors:  Christian Freise; Ki Young Kim; Uwe Querfeld
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-30       Impact factor: 2.629

9.  Alliin, a garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytes.

Authors:  Saray Quintero-Fabián; Daniel Ortuño-Sahagún; Manuel Vázquez-Carrera; Rocío Ivette López-Roa
Journal:  Mediators Inflamm       Date:  2013-12-26       Impact factor: 4.711

10.  An ethanolic extract of Lindera obtusiloba stems, YJP-14, improves endothelial dysfunction, metabolic parameters and physical performance in diabetic db/db mice.

Authors:  Jung-Ok Lee; Cyril Auger; Dong Hyun Park; Moonkyu Kang; Min-Ho Oak; Kyoung Rak Kim; Valérie B Schini-Kerth
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.